NHS Generic Pharmaceuticals - Wave 17a

NHS England

Value
£624,000,000
Published
4 Sept 2026
Deadline
Not stated
Procedure
Open procedure
Category
33600000 — Pharmaceutical products
Location
UKC, United Kingdom
Notice reference
083832-2026

Requirements summary

NHS England is planning an open-procedure framework procurement for generic pharmaceuticals under Wave 17a, covering DLS and DNE (London South, North East and Yorkshire) and oral and housekeeping products for the remaining regions. The estimated value is GBP 624,000,000 gross (GBP 520,000,000 net), with a planned contract period from 1 February 2029 to 31 January 2031 and possible extension to 31 January 2033. Commencement and award are subject to budgetary approval.

Key requirements

  • Supply of generic pharmaceuticals under NHS Wave 17a, covering DLS and DNE (London South, North East and Yorkshire) and oral products
  • Housekeeping products for the remaining regions
  • Delivery across 9 English regions (UKC to UKK, including London, Yorkshire, and the South East)
  • Framework agreement with SME suitability and a renewal option
  • Contract period 1 Feb 2029 to 31 Jan 2031, with a maximum extent to 31 Jan 2033
  • Estimated value GBP 624m gross (GBP 520m net), subject to budgetary approval
  • Future notice expected by 1 May 2028
NHS Generic Pharmaceuticals - Wave 17a — NHS England | ProposAI